C2H
メニュー
About C2H
Who we are
Members
Links
Access
What we do
Drug price setting
Necessity of evaluation
Concept of cost-effecitveness
Evaluation of costs
Evaluation of outcome
Example
Other countries (1)
Other countries (2)
Application in Japan
Roles of C2H
Results
Results (~2019.3)
Results (2019.4~)
Tools
Guideline and others
Related literatures
PBMs
Database
Abbreviations
Latest news
News
Events
Reports
For experts
For clinicians/citizens
Contact us
Japanese
search
Who we are
C2H Members
Links
Access
Links
Organizations (Domestic)
National Institute of Public Health
Ministry of Health, Labour and Welfare
Academic Societies and Organizations
HTAi
INAHTA
HTAsiaLink
Results of assessment/appraisal by HTA agency
NICE (England)
AWMSG (Wales)
SMC (Scotland)
CADTH CDR (Canada) [Prescription drugs]
CADTH pCODR (Canada) [Anticancer drugs]
INESSS (Québec, Canada)
PBAC (Australia)
PHARMAC (NZ)
NCPE (Ireland)
IQWiG (Germany)
G-BA (Germany) [in German]
HAS (France) [in French]
TLV (Sweden) [in Swedish]
NT council (Sweden) [in Swedish]
HITAP (Thailand)
ICER (US , NPO)